Zhang, Jingsong <br/><br/>
Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.  [electronic resource] 

 -  Asian journal of andrology   
 - 401-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1745-7262 
<br/><br/><label>Standard No.: </label>10.4103/1008-682X.123684  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>BRCA2 Protein--genetics<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Enzyme Inhibitors--therapeutic use<br/>Humans<br/>Hypoxia--genetics<br/>Male<br/>Mutation<br/>PTEN Phosphohydrolase--genetics<br/>Poly (ADP-Ribose) Polymerase-1<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Prostatic Neoplasms--drug therapy<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Proto-Oncogene Proteins c-ets--genetics<br/>Rad51 Recombinase--genetics<br/>Tumor Suppressor Protein p53--genetics